Frequently asked questions about MEDI-Q
F.A.Q. - Use and interpretation of MEDI-Q
What time period does the MEDI-Q assess?
The MEDI-Q evaluates menstrual cycles over the past 12 months. This extended time frame provides a comprehensive view of menstruation-related distress and its patterns. Repeating the questionnaire periodically is recommended to track any changes or trends over time.
Do all menstrual cycles need to be present during the assessed period?
No, the MEDI-Q accounts for potential irregularities. It was validated for use in individuals who have experienced at least three menstrual cycles within the past 12 months (the assessed period). However, it is not recommended for use if fewer than three cycles occurred during this time.
Can a woman use the MEDI-Q if she is experiencing amenorrhea?
Yes, the MEDI-Q can be used by women with amenorrhea, provided they have experienced at least three menstruations in the past 12 months (the assessed period). The questionnaire focuses on the menstrual cycles that occurred during this time, and the scores reflect the distress related to those menstruations, not the period of amenorrhea.
Can a woman use the MEDI-Q if she is taking hormonal contraceptives (e.g., the pill)?
Yes, the MEDI-Q can be used by women taking hormonal contraceptives. Keep in mind that these medications can influence menstrual distress, and consequently, the MEDI-Q scores may reflect these changes. This makes the questionnaire a valuable tool for monitoring menstrual distress before and after starting hormonal contraceptives, helping to track any variations over time.
How do I know if my score indicates high levels of menstrual distress?
A total MEDI-Q score of 20 or higher may suggest clinically relevant menstrual distress. This cutoff was determined based on research conducted with the Italian population and reflects the point at which menstrual-related symptoms are likely to significantly impact daily functioning.
However, please note that this cutoff is currently validated only for individuals within the Italian cultural and linguistic context. Scores may vary across different cultures and languages due to differences in symptom perception and reporting. If you are using this tool, always interpret your results with caution and consider consulting a healthcare professional for personalized advice.
What should I do if the MEDI-Q reports high levels of menstrual distress?
High levels of menstrual distress reported by the MEDI-Q can indicate the need for further attention, but the next steps depend on your personal situation. While the MEDI-Q is a robust, validated tool used worldwide, it is a screening instrument and not a definitive diagnostic tool. Always discuss your results and subjective experiences with your doctor or gynecologist. They will provide personalized advice and guide you on any necessary follow-up actions or treatments.
F.A.Q. - Research and other topics
Is the MEDI-Q available in my language?
If you don’t see your language on the download page, the MEDI-Q has not yet been officially validated in that language by our team. Please note that this page only hosts adaptations and validations developed or directly supervised by the original authors — independent translations may exist, but are not listed here. That said, stay tuned! We regularly receive validation proposals from researchers and professionals worldwide, so new official versions may be added soon. Keep checking back for updates.
Can I use the MEDI-Q for my research or clinical project?
Yes, the MEDI-Q is freely available for use in both research and clinical projects. To ensure proper acknowledgment, please make sure to correctly cite the article detailing the original validation of the MEDI-Q, as well as the article describing the cultural adaptation for your specific language, if applicable.
Can I translate and validate the MEDI-Q in my language?
Yes, the MEDI-Q is freely usable for translation and validation purposes. However, it is essential to follow established research practices and methodologies for cultural adaptations and validations. This includes steps like forward and backward translation, expert panel reviews, and pilot testing to ensure conceptual and semantic equivalence in the new language. For guidance, you can refer to the original validation and translation procedures of the MEDI-Q if needed.
Under what license is MEDI-Q distributed?
MEDI-Q is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). Read the CC BY-NC 4.0 license for more details.
Can I use MEDI-Q for a sponsored clinical trial on a commercial product?
We interpret the NC (Non-Commercial) clause in the CC-BY-NC 4.0 license as allowing use in sponsored research as long as the tool itself is not being sold and direct profit is not made from the use of MEDI-Q. Consequently, MEDI-Q can be freely used in sponsored research.
I'm having difficulties in scoring the MEDI-Q. How can I be sure I'm following the instructions correctly?
If you're encountering challenges with scoring the MEDI-Q, refer to the Resources for Researchers section on this website. There, you will find tools to assist you, including programmatic scoring code and an Excel spreadsheet designed for automatic scoring. These resources can help you verify your results and ensure accuracy in your scoring process.
Can I use new cutoff values for categorizing MEDI-Q results to ease interpretation?
Currently, the only validated cutoff for the MEDI-Q is a score of 20 or higher, which indicates clinically relevant menstrual distress. This cutoff was validated in the Italian population. While you are encouraged to explore and validate new cutoff values, it is crucial to adhere to high standards of clinical research. Ensure that your proposed cutoffs are supported by robust study designs, appropriate methodologies, and statistical analyzes, including validation of criterion validity. Publishing your findings in a reputable peer-reviewed journal is essential so that other researchers can replicate and further validate these cutoffs in different cultures and languages.
It is important to avoid using arbitrary or non-evidence-based cutoffs, as these may compromise the validity and reliability of the MEDI-Q's results.
How should I analyze results related to the MEDI-Q? Which statistical analyzes should I use?
MEDI-Q results can be analyzed as quantitative continuous variables, which allows for detailed and nuanced statistical analyzes. This approach preserves the full resolution of the data and provides greater statistical power. Common statistical methods include descriptive statistics, correlation analysis, regression models, and comparisons between groups using parametric or non-parametric tests, depending on the data distribution.
Alternatively, results can be dichotomized into "low" versus "high" distress levels using the validated cutoff score of 20 or more, which indicates clinically relevant menstrual distress (validated in the Italian population). However, this dichotomization reduces data granularity and may lower statistical power. Therefore, it is recommended to use this approach only as a complementary analysis alongside continuous variable methods.
For guidance on specific methodologies, refer to existing literature that uses the MEDI-Q in both general and clinical populations. This can provide examples of appropriate study designs and statistical techniques tailored to your research objectives.
Can I remove one or more items from the version of MEDI-Q that I am adapting for my cultural context?
The choice of items in the original version of MEDI-Q is the result of a long and careful selection process carried out by a multidisciplinary team that included specialists from various branches of medicine and social sciences, including gynecologists, psychiatrists, and psychologists. At present, we do not believe that one or more items of MEDI-Q can be removed without significantly altering the meaning of the score obtained or the functioning of the instrument. However, we understand that in some particular cultural contexts, certain sensitive items, such as those related to sexuality, may be difficult to administer. In any case, if your adaptation involves the removal of items, it is appropriate to rename the resulting version accordingly (e.g., "MEDI-Q-NS [Non-Sexual]").